Blood tests show 14% of people are now immune to covid-19 in one town in Germany
How many people have really been infected by the coronavirus? In one German town a preliminary answer is in: about 14%.
The municipality of Gangelt, near the border with the Netherlands, was hard hit by covid-19 after a February carnival celebration drew thousands to the town, turning it into an accidental petri dish.
More on coronavirus
Our most essential coverage of covid-19 is free, including:
How does the coronavirus work?
What are the potential treatments?
What's the right way to do social distancing?
Other frequently asked questions about coronavirus
Newsletter: Coronavirus Tech Report
Zoom show: Radio Corona
Please click here to subscribe and support our non-profit journalism.
Now, after searching blood from 500 residents for antibodies to the virus, scientists at a nearby university say they have determined that one in seven have been infected and are therefore “immune.” Some of those people would have had no symptoms at all.
Their brief report (PDF), posted online in German, has big implications for how soon that town, and the rest of the world, can come out from lockdown.
“To me it looks like we don’t yet have a large fraction of the population exposed,” says Nicholas Christakis, a doctor and social science researcher at Yale University. “They had carnivals and festivals, but only 14% are positive. That means there is a lot more to go even in a hard-hit part of Germany.”
Here's why the true infection rate in a region matters: the bigger it is, the less pain still lies ahead. Eventually, when enough people are immune—maybe half to three-quarters of us—the virus won’t be able to spread further, a concept called herd immunity.
But the German town isn’t close to that threshold yet, and to Christakis the preliminary figure is “unfortunate” because it means the virus still has more damage to do.
The German report is among the first to survey a population for evidence of prior infection, data that scientists need to determine how far the pandemic has spread, what the real death rate is, and how many people show no symptoms at all.
“It’s very preliminary, but it’s the kind of study we desperately need,” says Christakis, who believes the US should test as many as 200,000 people, from big cities like New York to small towns in the Midwest. “This is crucial to quantify a host of basic parameters.”
Globally, the official case count of covid-19 is more than 1.5 million people, but that reckoning mostly includes people who seek medical help and get tested. The true number of people infected, including those without symptoms and who don’t get tested, is far higher.
More data from "sero-surveys" should be available soon; sources include US hospitals. On April 6, Stanford Medicine announced it had launched its own serology test and had begun screening doctors, nurses, and others for antibodies.
“The test will enable us to determine which health-care workers might be at low risk for working with covid-19 patients, as well as understanding disease prevalence in our communities,” said spokesperson Lisa Kim.
Early results from hospitals are already circulating among some experts, says Christakis, who thinks these data will get us “closer to the truth” about how far the infection has spread in US cities. “If you see 5% positive in your health-care workers, that means infection rates probably aren’t higher than that in your city,” he says.
The survey in Germany was carried out by virologist Hendrik Streeck and several others at the University Hospital in Bonn, who say they approached about 1,000 residents of Gangelt to give blood, have their throats swabbed, and fill out a survey.
They found that 2% of residents were actively infected by the coronavirus and a total of 14% had antibodies, indicating a prior infection. This group of people, they say, “can no longer be infected with SARS-CoV-2,” as the virus is known to scientists.
As the virus spreads, it sends a certain percentage of people to the hospital and a few of those to ICUs; a portion of those will die. One of the biggest unanswered questions is exactly what percentage of infected people the coronavirus is killing.
From the result of their blood survey, the German team estimated the death rate in the municipality at 0.37% overall, a figure significantly lower than what’s shown on a dashboard maintained by Johns Hopkins, where the death rate in Germany among reported cases is 2%.
The authors explain that the difference in the calculations boils down to how many people are actually infected but haven’t been counted because they have mild or no symptoms.
The presence of previously infected people in the community, Streeck and colleagues believe, will reduce the speed at which the virus can move in the area. They also outline a process by which social distancing can be slowly unwound, especially given hygienic measures, like handwashing, and isolating and tracking the sick. They think if people avoid getting big doses of the virus—which can happen in hospitals or via close contact with someone infected—fewer people will become severely ill, “while at the same time developing immunity” that can help finally end the outbreak.
—with reporting by James Temple
A brain implant changed her life. Then it was removed against her will.
Her case highlights why we need to enshrine neuro rights in law.
The first babies conceived with a sperm-injecting robot have been born
Meet the startups trying to engineer a desktop fertility machine.
Doctors have performed brain surgery on a fetus in one of the first operations of its kind
A baby girl who developed a life-threatening brain condition was successfully treated before she was born—and is now a healthy seven-week-old.
Longevity enthusiasts want to create their own independent state. They’re eyeing Rhode Island.
Zuzalu, a pop-up city in Montenegro has provided a temporary home for people who plan to set up a new jurisdiction to encourage biohacking and fast-track drugs that slow or reverse aging.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.